These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 32374045

  • 1. Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach.
    Crisi G, Filice S.
    J Neuroimaging; 2020 Jul; 30(4):458-462. PubMed ID: 32374045
    [Abstract] [Full Text] [Related]

  • 2. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y, Patel M, Natarajan K, Ughratdar I, Sanghera P, Jena R, Watts C, Sawlani V.
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [Abstract] [Full Text] [Related]

  • 3. Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.
    Yoon RG, Kim HS, Paik W, Shim WH, Kim SJ, Kim JH.
    Eur Radiol; 2017 Jan; 27(1):255-266. PubMed ID: 27048531
    [Abstract] [Full Text] [Related]

  • 4. MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features.
    Choi HJ, Choi SH, You SH, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Park CK, Park SH.
    AJNR Am J Neuroradiol; 2021 May; 42(5):853-860. PubMed ID: 33632732
    [Abstract] [Full Text] [Related]

  • 5. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S, Rui Q, Wang Y, Heo HY, Zou T, Yu H, Zhang Y, Wang X, Du Y, Wen X, Chen F, Wang J, Eberhart CG, Zhou J, Wen Z.
    Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
    [Abstract] [Full Text] [Related]

  • 6. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
    Li ZC, Bai H, Sun Q, Li Q, Liu L, Zou Y, Chen Y, Liang C, Zheng H.
    Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
    [Abstract] [Full Text] [Related]

  • 7. The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter.
    Choi YS, Ahn SS, Lee HJ, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1528-1535. PubMed ID: 28642265
    [Abstract] [Full Text] [Related]

  • 8. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB, Guo F, Xu ZL, Li C, Wei W, Tian P, Liu TT, Liu L, Chen G, Ye J, Cheng G, Cui LB, Zhang HJ, Qin W, Yin H.
    J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
    [Abstract] [Full Text] [Related]

  • 9. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
    Han Y, Yan LF, Wang XB, Sun YZ, Zhang X, Liu ZC, Nan HY, Hu YC, Yang Y, Zhang J, Yu Y, Sun Q, Tian Q, Hu B, Xiao G, Wang W, Cui GB.
    BMC Cancer; 2018 Feb 21; 18(1):215. PubMed ID: 29467012
    [Abstract] [Full Text] [Related]

  • 10. Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis.
    Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ.
    AJNR Am J Neuroradiol; 2018 Aug 21; 39(8):1439-1445. PubMed ID: 30002055
    [Abstract] [Full Text] [Related]

  • 11. Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients.
    Bani-Sadr A, Berner LP, Barritault M, Chamard L, Bidet CM, Eker OF, Hermier M, Guyotat J, Jouanneau E, Meyronet D, Gouttard S, D'Hombres A, Iziquierdo C, Honnorat J, Berthezène Y, Ducray F.
    Rev Neurol (Paris); 2019 Oct 21; 175(9):534-543. PubMed ID: 31208813
    [Abstract] [Full Text] [Related]

  • 12. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
    Yoo RE, Yun TJ, Hwang I, Hong EK, Kang KM, Choi SH, Park CK, Won JK, Kim JH, Sohn CH.
    Eur Radiol; 2020 Feb 21; 30(2):1202-1211. PubMed ID: 31468161
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas.
    Lu J, Li X, Li H.
    Magn Reson Imaging; 2021 Nov 21; 83():189-195. PubMed ID: 34506909
    [Abstract] [Full Text] [Related]

  • 17. MGMT-Positive vs MGMT-Negative Patients With Glioblastoma: Identification of Prognostic Factors and Resection Threshold.
    Katsigiannis S, Grau S, Krischek B, Er K, Pintea B, Goldbrunner R, Stavrinou P.
    Neurosurgery; 2021 Mar 15; 88(4):E323-E329. PubMed ID: 33432978
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status.
    Kong DS, Kim ST, Kim EH, Lim DH, Kim WS, Suh YL, Lee JI, Park K, Kim JH, Nam DH.
    AJNR Am J Neuroradiol; 2011 Feb 15; 32(2):382-7. PubMed ID: 21252041
    [Abstract] [Full Text] [Related]

  • 19. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
    Korfiatis P, Kline TL, Coufalova L, Lachance DH, Parney IF, Carter RE, Buckner JC, Erickson BJ.
    Med Phys; 2016 Jun 15; 43(6):2835-2844. PubMed ID: 27277032
    [Abstract] [Full Text] [Related]

  • 20. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.
    Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI.
    J Neurooncol; 2017 Jul 15; 133(3):615-622. PubMed ID: 28536992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.